chr11-108268456-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000051.4(ATM):​c.2685A>G​(p.Leu895Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00243 in 1,614,020 control chromosomes in the GnomAD database, including 91 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. L895L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.013 ( 52 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 39 hom. )

Consequence

ATM
NM_000051.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:25

Conservation

PhyloP100: -1.50

Publications

14 publications found
Variant links:
Genes affected
ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]
ATM Gene-Disease associations (from GenCC):
  • ATM-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • ataxia telangiectasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • gastric carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-108268456-A-G is Benign according to our data. Variant chr11-108268456-A-G is described in ClinVar as Benign. ClinVar VariationId is 140770.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.5 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0129 (1957/152292) while in subpopulation AFR AF = 0.0438 (1821/41550). AF 95% confidence interval is 0.0422. There are 52 homozygotes in GnomAd4. There are 873 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 52 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
NM_000051.4
MANE Select
c.2685A>Gp.Leu895Leu
synonymous
Exon 18 of 63NP_000042.3
ATM
NM_001351834.2
c.2685A>Gp.Leu895Leu
synonymous
Exon 19 of 64NP_001338763.1Q13315

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATM
ENST00000675843.1
MANE Select
c.2685A>Gp.Leu895Leu
synonymous
Exon 18 of 63ENSP00000501606.1Q13315
ATM
ENST00000452508.7
TSL:1
c.2685A>Gp.Leu895Leu
synonymous
Exon 19 of 64ENSP00000388058.2Q13315
ATM
ENST00000531525.3
TSL:1
c.2685A>Gp.Leu895Leu
synonymous
Exon 18 of 30ENSP00000434327.3H0YDU7

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1950
AN:
152174
Hom.:
52
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0438
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00648
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00355
AC:
892
AN:
251356
AF XY:
0.00252
show subpopulations
Gnomad AFR exome
AF:
0.0479
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000194
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00135
AC:
1967
AN:
1461728
Hom.:
39
Cov.:
31
AF XY:
0.00119
AC XY:
868
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.0451
AC:
1511
AN:
33476
American (AMR)
AF:
0.00271
AC:
121
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39666
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53354
Middle Eastern (MID)
AF:
0.00278
AC:
16
AN:
5764
European-Non Finnish (NFE)
AF:
0.000122
AC:
136
AN:
1111968
Other (OTH)
AF:
0.00290
AC:
175
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
95
191
286
382
477
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0129
AC:
1957
AN:
152292
Hom.:
52
Cov.:
32
AF XY:
0.0117
AC XY:
873
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0438
AC:
1821
AN:
41550
American (AMR)
AF:
0.00647
AC:
99
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68026
Other (OTH)
AF:
0.00945
AC:
20
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
91
181
272
362
453
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00413
Hom.:
12
Bravo
AF:
0.0152
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000296

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
5
not provided (5)
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
-
3
Ataxia-telangiectasia syndrome (3)
-
-
2
Familial cancer of breast (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Hereditary breast ovarian cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.3
DANN
Benign
0.49
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3218687; hg19: chr11-108139183; API